Actor and advocate Brooke Shields says learning how to embrace aging and prioritize preventive health in her 50s feels "like ...

The Food and Drug Administration had recently approved a new drug for the treatment of atopic dermatitis (eczema), which can ...

My hands shook as I texted my husband. I felt unmoored in my body, as if I’d awoken in a different house than the one where I ...

Ebglyss is a new biologic treatment for moderate-to-severe eczema that isn’t controlled with topical therapies. The ...

A New Target for Treatment of One Type of Macular Degeneration ... June 7, 2024 — New eye-tracking research has shown that simply looking at natural elements during urban walks can offer ...

EBGLYSS is an FDA-approved drug for treating moderate-to-severe eczema by targeting IL-13, offering relief to patients ...

Multiple artists we spoke to unanimously agreed that the brand Viseart makes some of the best eye-shadow palettes on the ...

There are a number of treatment options for ED. Initially, a provider may advise the patient to take steps to improve their lifestyle habits, such as increasing their level of physical activity ...

The US Food and Drug Administration (FDA) has approved the targeted interleukin (IL)-13 inhibitor lebrikizumab (Ebglyss) for ...

PHN is characterised by pain lasting from three months to several years after the rash subsides, and it is also the most ...

The US food and Drug Administration has approved lebrikizumab for treatment of atopic dermatitis in adults and children ages ...